Received Aug 26, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| DTPPVHBHPB | DTAP+IPV+HIB+HEPB (VAXELIS) | MSP VACCINE COMPANY | 1 | U7947AA | IM / RL |
| IPV | POLIO VIRUS, INACT. (IPOL) | SANOFI PASTEUR | UNK | Y1A201M | IM |
| PNC20 | PNEUMO (PREVNAR20) | PFIZER\WYETH | UNK | — | — |
| RV1 | ROTAVIRUS (ROTARIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | — | — |
No adverse event; received a dose of VAXELIS, which has the Polio, and the patient also received an extra Ipol; received a dose of VAXELIS, which has the Polio, and the patient also received an extra Ipol; Patient receiving his first dose of VAXELIS past the recommended schedule; This non-serious, spontaneous safety report with reference number: 2025SA193061, 02583395, and 02583320 was received by a partner on 08-JUL-2025 and forwarded to agency on 09-JUL-2025 from a nurse. Due to the nature of the event, the causality between the event "received a dose of VAXELIS, which has the Polio, and the patient also received an extra Ipol", and "patient receiving his first dose of VAXELIS past the recommended schedule." and Vaxelis are not applicable. Further information is expected. FOLLOW-UP INFORMATION was received by partner, on 07-AUG-2025 and forwarded to agency on 08-AUG-2025 from a health professional. The case is maintained as non-serious. Due to the nature of the event, the causality between the events "received a dose of VAXELIS, which has the Polio, and the patient also received an extra Ipol", and "patient receiving his first dose of VAXELIS past the recommended schedule." and "no adverse event" and Vaxelis are not applicable. No further information is expected. CASE CORRECTION performed on 22-AUG-2025. Patient age at vaccination, date of birth, height and weight was corrected.
Prophylaxis